004310.KS
Hyundai Pharmaceutical Co., Ltd.
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 6,680.00
−2.91%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 55.28x
- PEG TTM
- 14.32x
- Price / book
- 1.36x
- Price / sales
- 0.85x
- Price / cash flow
- 17.05x
Enterprise value
- Enterprise value
- KRW 201.9B
- EV / sales
- 0.98x
- EV / EBITDA
- 19.45x
- EV / EBIT
- 37.63x
- Market cap
- KRW 175.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Aug 1, 2026